12:00 AM
 | 
May 17, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Taxus Element Stent regulatory update

Boston Scientific received CE mark approval in the EU for its Taxus Element Stent to treat coronary arterial disease (CAD). The company noted that...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >